The problem with treating Alzheimer’s is that once the symptoms start showing up, it’s already too late—meaning that early detection is absolutely vital in coming up with working solutions. Using the power of machine learning, IBM researchers have figured out a way to detect a biological marker associated with the disease through a simple blood test. Apparently, that biological marker, which is found in spinal fluid, starts changing decades before the first signs of the disease show up. The problem is harvesting spinal fluid for testing is highly invasive and expensive, making it not ideal for an early detection procedure. What the IBM scientists have figured out is that it’s possible to identify the proteins in the blood that can predict the concentration of the biomarker in spinal fluid, making early detection not only possible but also affordable. The method is still in its early stages of testing, but in the future, scientists could use it to find appropriate subjects for programs developing a cure.
IBM is using machine learning to detect Alzheimer’s way before symptoms show up
More of Today's Solutions
This series will take you to the world’s most ingenious homes
We at the Optimist Daily are always curious about the latest developments in architecture and design. It came to our attention that Apple TV+ has ...
Read MoreThree types of plants that will thrive in your kitchen
There’s nothing like a little indoor greenery to brighten up your home, especially if you live in an apartment where there’s no space for ...
Read MoreSelf-sustaining batteries powered by the body’s oxygen
Imagine a world in which medical implants may run perpetually without the need for battery refills. This futuristic potential could soon become a reality ...
Read MoreHow to listen like a therapist with four ways to build deeper connection and ...
BY THE OPTIMIST DAILY EDITORIAL TEAM We often underestimate the power of truly being heard. But anyone who’s experienced the relief of someone really ...
Read More
